Ray Dalio's MDT Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 282,386 shares of Medtronic plc (MDT) worth $27.13 M, representing 0.10% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in MDT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 1.88 M shares. Largest reduction occurred in Q3 2022, reducing 2.51 M shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Medtronic plc (MDT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medtronic plc (MDT) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -55,815 | Reduce 16.50% | 282,386 | $96.06 |
| Q3 2025 | +136,035 | Add 67.29% | 338,201 | $95.24 |
| Q2 2025 | +32,570 | Add 19.20% | 202,166 | $87.17 |
| Q1 2025 | -341,753 | Reduce 66.83% | 169,596 | $89.86 |
| Q4 2024 | -71,379 | Reduce 12.25% | 511,349 | $79.88 |
| Q3 2024 | -796,240 | Reduce 57.74% | 582,728 | $90.03 |
| Q2 2024 | +698,741 | Add 102.72% | 1.38 M | $78.71 |
| Q1 2024 | +680,227 | New Buy | 680,227 | $87.15 |
| Q3 2022 | -2.51 M | Sold Out | 0 | $0.00 |
| Q2 2022 | +625,168 | Add 33.25% | 2.51 M | $89.75 |
| Q1 2022 | +1.88 M | New Buy | 1.88 M | $110.95 |
| Q1 2018 | -25,152 | Sold Out | 0 | $0.00 |
| Q4 2017 | +25,152 | New Buy | 25,152 | $80.75 |
| Q1 2017 | -62,300 | Sold Out | 0 | $0.00 |
| Q4 2016 | +31,300 | Add 100.97% | 62,300 | $71.24 |
| Q3 2016 | +31,000 | New Buy | 31,000 | $86.39 |
| Q1 2016 | -53,186 | Sold Out | 0 | $0.00 |
| Q4 2015 | -4,000 | Reduce 6.99% | 53,186 | $76.92 |
| Q3 2015 | -27,946 | Reduce 32.83% | 57,186 | $66.94 |
| Q2 2015 | -87,700 | Reduce 50.74% | 85,132 | $74.10 |
| Q1 2015 | +172,832 | New Buy | 172,832 | $77.99 |
Ray Dalio's Medtronic plc Investment FAQs
Ray Dalio first purchased Medtronic plc (MDT) in Q1 2015, acquiring 172,832 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Medtronic plc (MDT) for 21 quarters since Q1 2015.
Ray Dalio's largest addition to Medtronic plc (MDT) was in Q1 2022, adding 1,880,088 shares worth $208.6 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 282,386 shares of Medtronic plc (MDT), valued at approximately $27.13 M.
As of the Q4 2025 filing, Medtronic plc (MDT) represents approximately 0.10% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Medtronic plc (MDT) was 2,505,256 shares, as reported at the end of Q2 2022.